Format

Send to

Choose Destination
Nanotoxicology. 2013 Sep;7(6):1131-42. doi: 10.3109/17435390.2012.710661. Epub 2012 Aug 13.

Titanate nanotubes: towards a novel and safer nanovector for cardiomyocytes.

Author information

1
Laboratoire Interdisciplinaire Carnot de Bourgogne, UMR 6303 CNRS - Université de Bourgogne, BP 47870, Dijon cedex, France.

Abstract

Actively contractile cardiomyocyte (CM) monolayer represents an interesting tool to study both cardiac diseases and injuries. However, this model is poorly transfectable with conventional agents. Consequently, there is a need to develop new carriers that could overcome this problem. Titanate nanotubes (TiONts) could be a potential candidate due to possibly higher cell uptake as a direct consequence of their shape. On the basis of this rationale, TiONts were assessed for their cytotoxicity and internalization pathways. Cytotoxicity was assessed for TiONts either functionalized with PEI or unfunctionalized and its spherical counterpart P25 TiO2. No cytotoxic effect was observed under TiONts, TiONts-PEI1800 and P25 TiO2 exposed conditions. The tubular morphology was found to be an important parameter promoting internalization while reversing the charge was assessed as non-additional. Internalization was found to occur by endocytosis and diffusion through the membrane. A preliminary transfection study indicated the potential of TiONts as a nanocarrier.

PMID:
22770363
DOI:
10.3109/17435390.2012.710661
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center